Paper14433
Prevention of pneumococcal pneumonia by vaccination.
Austrian R and 6 others. Trans Assoc Am Physicians, 1976. Cited by 235 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Prevention of pneumococcal pneumonia by vaccination. Papers, record 14433. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14433
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Vaccines | Major topic |
| Pneumonia, Pneumococcal | Major topic |
| Vaccination | Major topic |
| Antigens, Bacterial | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Sepsis | |
| Streptococcus pneumoniae |
Source PubMed
Cited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 235 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,620,135 | [Guidelines for the management of community pneumonia in adult who needs hospitalization]. | Med Intensiva | 2005 | https://conductscience.org/library/papers/38620135 | PubMed |
| 36,153,636 | The remarkable history of pneumococcal vaccination: an ongoing challenge. | Pneumonia (Nathan) | 2022 | https://conductscience.org/library/papers/36153636 | PubMed |
| 34,590,137 | Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe. | J Infect Dis | 2021 | https://conductscience.org/library/papers/34590137 | PubMed |
| 34,019,468 | Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older. | Hum Vaccin Immunother | 2021 | https://conductscience.org/library/papers/34019468 | PubMed |
| 32,286,171 | How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine. | Viral Immunol | 2020 | https://conductscience.org/library/papers/32286171 | PubMed |
| 30,700,048 | The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects. | Vaccines (Basel) | 2019 | https://conductscience.org/library/papers/30700048 | PubMed |
| 30,337,597 | Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation. | Sci Rep | 2018 | https://conductscience.org/library/papers/30337597 | PubMed |
| 29,261,406 | Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations. | Hum Vaccin Immunother | 2018 | https://conductscience.org/library/papers/29261406 | PubMed |
| 28,116,747 | Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28116747 | PubMed |
| 28,061,505 | Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis. | PLoS One | 2017 | https://conductscience.org/library/papers/28061505 | PubMed |
| 27,009,210 | Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right? | Clin Vaccine Immunol | 2016 | https://conductscience.org/library/papers/27009210 | PubMed |
| 27,002,793 | Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/27002793 | PubMed |
| 24,925,139 | From empiricism to rational design: a personal perspective of the evolution of vaccine development. | Nat Rev Immunol | 2014 | https://conductscience.org/library/papers/24925139 | PubMed |
| 24,732,438 | Preventing non bacteremic pneumococcal pneumonia in older adults: historical background and considerations for choosing between PCV13 and PPV23. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/24732438 | PubMed |
| 24,030,320 | Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/24030320 | PubMed |
| 23,732,892 | Pneumococcal vaccination of older adults: conjugate or polysaccharide? | Hum Vaccin Immunother | 2013 | https://conductscience.org/library/papers/23732892 | PubMed |
| 23,675,550 | Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans. | PLoS Negl Trop Dis | 2013 | https://conductscience.org/library/papers/23675550 | PubMed |
| 23,440,780 | Vaccines for preventing pneumococcal infection in adults. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23440780 | PubMed |
| 22,500,271 | Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. | Aging Dis | 2012 | https://conductscience.org/library/papers/22500271 | PubMed |
| 21,963,800 | The development of vaccines: how the past led to the future. | Nat Rev Microbiol | 2011 | https://conductscience.org/library/papers/21963800 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14433
GET https://conductscience.org/api/papers/v1/14433/cited_by?page=2